Value of the diagnostic algorithm in differentiating glioblastoma from solitary brain metastasis and primary central nervous system lymphomas using Dynamic susceptibility contrast-enhanced MRI (DSCE-MRI) and Proton magnetic resonance spectroscopy (1H-MRS).